Valuation
26% of the score, 30% here after data gaps
0median 13
An operating loss over the last year: there are no earnings to price.
MDGLMadrigal Pharmaceuticals, Inc.
$517.72+14% 1Y
$517.72
$412.3552 weeks$602.83
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 18 out of 100, Weak
Weak. Madrigal Pharmaceuticals, Inc. scores higher than 16% of the 1,794 companies Ryufin scores.
Carried by earnings quality, held back by valuation and return on capital.
Healthcare median 27 · all companies 50
Return on capital
18% of the score, 20% here after data gaps
0median 34
Over 7 years the business earned n/a a year after tax on the capital it uses.
Return on new capital
16% of the score, 18% here after data gaps
0median 49
No operating profit over the period, so nothing was earned to reinvest.
Capital allocation
14% of the score, 16% here after data gaps
40median 64
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countUp 7.8% a year over 5 years: new shares
05%
-3%
7.8%
0 pointsfull points
Assets against salesAssets grew 21% a year, sales 97%
10012%
-2%
-75%
0 pointsfull points
Cycle position
Taken out: its 12% is shared by the others
n/ano data
Fewer than five years of margins on file.
Balance sheet
8% of the score, 9% here after data gaps
50median 50
What the debt weighs against the profit that has to carry it.
Net debt to EBITDAMore cash than debt
100Interest coverOperating profit covers interest -10x
01.5x
12x
-10.2x
0 pointsfull points
Earnings quality
6% of the score, 7% here after data gaps
100median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
AccrualsCash ran ahead of profit by 8.6% of assets
1008%
0%
-8%
-8.6%
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. For MDGL, cycle position could not be measured from the filings, so it is taken out and the remaining weights scale up.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.